Recent technical advances in synthetic biology are being driven by data, computation, automation and high-throughput robotics which are fundamentally advancing the industry. Leaders in the field share their visions for synthetic biology and challenges in the age of the cloud on the path to building the networks and labs of the future. We will share lessons learned in creating highly functional consortiums of science and how to communicate about the science being performed.
Director of Science & Technology, Strateos
Co-Founder & CEO, Netrias
Principal Research Scientist, SIFT
Assoc. Prof. of Biology, Duke University
Scientific Technical Advisor, Gryphon Technologies
Sr. Engineer, Ginkgo Bioworks
Robotic cloud laboratories are making it possible for scientists to work from home.
What are the key takeaways from attending this SynBioBeta live?
Hear about advances in synthetic biology and current bottlenecks, and where the field may be trending
Learn about present-day synthetic biology work inclusive of SD2 and automates robotic cloud labs
Connect and build a mutually beneficial network within the synthetic biology community
Synthetic biology leaders share their visions of the future of the industry in the coming age of cloud-based labs and next-gen networking. In our special one-hour event, experts will engage in a round table discussion about the lessons they've learned in creating highly functional consortiums and the challenges of communicating scientific advances to the public. The event will conclude with a live Q&A.
Founder & CEO, SynBioBeta
John began his career at NASA Ames, in the heart of Silicon Valley, where he sought answers to how humans could live to visit the far reaches of our universe. Now at SynBioBeta, he works to empower a community of bio-entrepreneurs, companies, investors, researchers, visionaries, and thought leaders to bring projects to life. Through his leadership at SynBioBeta, John aims to facilitate the critical scientific and entrepreneurial collaborations that will shape the future of humanity.